Impact BioMedical Inc./$IBO
14:30
15:25
16:15
17:10
18:00
1D1W1MYTD1Y5YMAX
About Impact BioMedical Inc.
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Ticker
$IBO
Sector
Primary listing
AMEX
Employees
2
Headquarters
Website
IBO Metrics
BasicAdvanced
$47M
-
-$3.69
-
-
Price and volume
Market cap
$47M
52-week high
$6.17
52-week low
$0.36
Average daily volume
95K
Financial strength
Current ratio
0.039
Quick ratio
0.001
Total debt to equity
-258.455
Interest coverage (TTM)
-3.75%
Profitability
EBITDA (TTM)
-3.126
Gross margin (TTM)
92.00%
Net profit margin (TTM)
-176,764.00%
Operating margin (TTM)
-15,948.00%
Effective tax rate (TTM)
-0.07%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-7.68%
Return on equity (TTM)
-346.99%
Valuation
Price to revenue (TTM)
213.909
Price to book
-0.46
Price to tangible book (TTM)
-0.19
Price to free cash flow (TTM)
-1.323
Free cash flow yield (TTM)
-75.57%
Free cash flow per share (TTM)
-0.337
Growth
Earnings per share change (TTM)
-30,615.30%
3-year revenue growth (CAGR)
-20.63%
3-year earnings per share growth (CAGR)
325.62%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Impact BioMedical Inc. stock?
Impact BioMedical Inc. (IBO) has a market cap of $47M as of December 01, 2025.
What is the P/E ratio for Impact BioMedical Inc. stock?
The price to earnings (P/E) ratio for Impact BioMedical Inc. (IBO) stock is 0 as of December 01, 2025.
Does Impact BioMedical Inc. stock pay dividends?
No, Impact BioMedical Inc. (IBO) stock does not pay dividends to its shareholders as of December 01, 2025.
When is the next Impact BioMedical Inc. dividend payment date?
Impact BioMedical Inc. (IBO) stock does not pay dividends to its shareholders.
What is the beta indicator for Impact BioMedical Inc.?
Impact BioMedical Inc. (IBO) does not currently have a Beta indicator.